December 11, 2013
Bioniche Life Sciences Inc. Delisting Approved by the ASX
December 4, 2013
Primary and Long-Term Illness Related to E. coli O157 Costs $403.9 Million per Year in Canada
Latest TSX stock price
All prices delayed at least 15 minutes.Source: TSX Inc.
Latest ASX stock price
All prices delayed at least 20 minutes.Source: ASX Inc.
For Bioniche logos, product graphics, photography or video B-roll, please outline your requirement, intended use and preferred format by contacting firstname.lastname@example.org.